COVERAGE
Managing risks from PE portfolio company liabilities and VC pay-to-play financing provisions
April 16, 2026
Read time: 2 min

COVERAGE
April 16, 2026
Read time: 2 min

COVERAGE
April 16, 2026
Read time: 2 min

COVERAGE
April 16, 2026
Read time: 2 min

COVERAGE
April 16, 2026
Read time: 2 min
“The Court of Cassation has issued four rulings that change the landscape regarding the sanctions an employer can impose if an employee publicly makes insulting or defamatory remarks.”
Click here to read Jilali Maazouz’s commentary in Le Figaro (in French via paywall).

COVERAGE
April 15, 2026
Read time: 2 min

COVERAGE
April 13, 2026
Read time: 2 min

COVERAGE
April 10, 2026
Read time: 2 min

COVERAGE
April 10, 2026
Read time: 2 min

COVERAGE
April 10, 2026
Read time: 2 min
“In China, we have moved from single-asset–focused agreements to a collaborative model aimed at leveraging the country’s ability to accelerate clinical trials in a highly competitive environment. Chinese healthcare groups, for their part, are looking to use the phase III development, regulatory approval capabilities, and commercial strength of international pharmaceutical companies to subsequently bring their treatments to the US market.”
Read the full commentary with Emmanuelle Trombe in Pharmaceutiques (in French via paywall) here.

COVERAGE
April 8, 2026
Read time: 2 min